檢索結果 - Ernest Asante‐Appiah
- Showing 1 - 8 results of 8
-
1
-
2
Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs) 由 Tracy L. Diamond, Winnie Ngo, Min Xu, Shih Lin Goh, Silveria Rodriguez, Ming‐Tain Lai, Ernest Asante‐Appiah, Jay A. Grobler
出版 2022Artigo -
3
-
4
Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors 由 David R. McGivern, Takahiro Masaki, Sara E. Williford, Paul Ingravallo, Zongdi Feng, Frederick Lahser, Ernest Asante‐Appiah, Petra Neddermann, Raffaele De Francesco, A Howe, Stanley M. Lemon
出版 2014Artigo -
5
The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV G... 由 Frederick Lahser, Karin Bystol, Stephanie Curry, Patricia McMonagle, Ellen Xia, Paul Ingravallo, Robert A. Chase, Rong Liu, Todd A. Black, Daria J. Hazuda, Anita Y. M. Howe, Ernest Asante‐Appiah
出版 2016Artigo -
6
<i>In Vitro</i>Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor 由 Ming‐Tain Lai, Meizhen Feng, Jean‐Pierre Falgueyret, Paul Tawa, Marc Witmer, Daniel J. DiStefano, Yuan Li, Jason D. Burch, Nancy A. Sachs, Meiqing Lu, Elizabeth Cauchon, Louis‐Charles Campeau, Jay A. Grobler, Youwei Yan, Yves Ducharme, Bernard Côté, Ernest Asante‐Appiah, Daria J. Hazuda, Michael D. Miller
出版 2013Artigo -
7
Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers 由 I‐Ming Wang, Bin Zhang, Xia Yang, Jun Zhu, Serguei Stepaniants, Chunsheng Zhang, Qingying Meng, Mette A. Peters, Yudong D. He, Chester Ni, Deborah Slipetz, Michael A. Crackower, Hani Houshyar, Christopher M. Tan, Ernest Asante‐Appiah, Gary P. O’Neill, Mingjuan Luo, Rolf Thieringer, Jeffrey Yuan, Chi‐Sung Chiu, Pek Yee Lum, John R. Lamb, Yves Boie, Hilary Wilkinson, Eric E. Schadt, Hongyue Dai, Christopher J. Roberts
出版 2012Artigo -
8
Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms 由 Ling Tong, Wensheng Yu, Lei Chen, Oleg Selyutin, Michael P. Dwyer, Anilkumar G. Nair, Robert Mazzola, Jae‐Hun Kim, Deyou Sha, Jingjun Yin, Rebecca T. Ruck, Ian W. Davies, Bin Hu, Bin Zhong, Jinglai Hao, Tao Ji, Shuai Zan, Rong Liu, Sony Agrawal, Ellen Xia, Stephanie Curry, Patricia McMonagle, Karin Bystol, Frederick Lahser, Donna Carr, Laura L. Rokosz, Paul Ingravallo, Shiying Chen, Kung‐I Feng, Mark E. Cartwright, Ernest Asante‐Appiah, Joseph A. Kozlowski
出版 2016Artigo
相關主題
Biology
Gene
Biochemistry
Virology
Chemistry
Hepacivirus
NS5A
Virus
Antiretroviral therapy
Ecology
Endocrinology
Hepatitis C virus
Intracellular
Medicine
Mutant
NS3
RNA
Reverse transcriptase
Viral load
Amino acid
Cell biology
Computational biology
Drug resistance
Efavirenz
Endosome
Enzyme
Etravirine
Fluorescence
Fusion protein
Förster resonance energy transfer